“[T]he combination of tumor-associated Neu5Gc and [our] circulating anti-Neu5Gc autoantibodies promotes tumor growth, by inducing weak inflammation, causing infiltration of inflammatory cells and [enhancing] angiogenesis [enhanced blood flow to the tumor].”